Beta carboline derivatives useful in the treatment of proliferative disorders
US9168247B2 · kind B2 · utility
4Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 24, 2011 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Jun 24, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel beta-carboline derivatives of formulae (Ia) and (Ib) useful in the treatment of proliferative disorders including cancer, intermediates used in their preparation, processes for preparing the same and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.